Literature DB >> 8906277

Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes.

L Curatolo1, C Caccia, C Speciale, L Raimondi, M Cini, M Marconi, A Molinari, R Schwarcz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8906277     DOI： 10.1007/978-1-4613-0381-7_43

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

1.  Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).

Authors:  Katarzyna Wejksza; Wojciech Rzeski; Etsuo Okuno; Martyna Kandefer-Szerszen; Jan Albrecht; Waldemar A Turski
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory.

Authors:  Ana Pocivavsek; Hui-Qiu Wu; Michelle C Potter; Greg I Elmer; Roberto Pellicciari; Robert Schwarcz
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

Review 3.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.

Authors:  Katarzyna Wejksza; Wojciech Rzeski; Jolanta Parada-Turska; Barbara Zdzisinska; Robert Rejdak; Tomasz Kocki; Etsuo Okuno; Martyna Kandefer-Szerszen; Eberhart Zrenner; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-10       Impact factor: 3.000

5.  Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.

Authors:  T Zarnowski; M Bialek; R Rejdak; E Zrenner; A Junemann; Z Zagorski; T Kocki; W A Turski
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

6.  Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells.

Authors:  Nady Braidy; Helene Rossez; Chai K Lim; Bat-Erdene Jugder; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2016-08-10       Impact factor: 3.911

7.  Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons.

Authors:  L K Nilsson; K R Linderholm; S Erhardt
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.850
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.